Unicycive Therapeutics, Inc.

Unicycive Therapeutics, Inc.verified

UNCY

Price:

$0.684

Market Cap:

$71.00M

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.[Read more]

Industry

Biotechnology

IPO Date

2021-07-12

Stock Exchange

NASDAQ

Ticker

UNCY

The ROE as of December 2024 (TTM) for Unicycive Therapeutics, Inc. (UNCY) is -374.14%

According to Unicycive Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -374.14%. This represents a change of -619.15% compared to the average of 72.07% of the last 4 quarters.

Unicycive Therapeutics, Inc. (UNCY) Historical ROE (quarterly & annually)

How has UNCY ROE performed in the past?

The mean historical ROE of Unicycive Therapeutics, Inc. over the last ten years is 843.53%. The current -374.14% ROE has changed -144.35% with respect to the historical average. Over the past ten years (40 quarters), UNCY's ROE was at its highest in in the December 2022 quarter at 1.14%. The ROE was at its lowest in in the March 2023 quarter at -239.16%.

Quarterly (TTM)
Annual

Average

843.53%

Median

177.27%

Minimum

-64.50%

Maximum

3.88%

Unicycive Therapeutics, Inc. (UNCY) ROE by Quarter and Year

Discovering the peaks and valleys of Unicycive Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 180.65%

Maximum Annual ROE = 3.88%

Minimum Annual Increase = -6110.02%

Minimum Annual ROE = -64.50%

Quarterly (TTM)
Annual
YearROEChange
2023801.89%-79.31%
20223.88%-6110.02%
2021-64.50%-168.69%
202093.90%-63.97%
2019260.63%180.65%

Unicycive Therapeutics, Inc. (UNCY) Average ROE

How has UNCY ROE performed in the past?

The current ROE of Unicycive Therapeutics, Inc. (UNCY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.54%

5-year avg

993.66%

10-year avg

843.53%

Unicycive Therapeutics, Inc. (UNCY) ROE vs. Peers

How is UNCY’s ROE compared to its peers?

Unicycive Therapeutics, Inc.’s ROE is greater than TransCode Therapeutics, Inc. (-649.01%), greater than Ambrx Biopharma Inc. (-16.57%), greater than Cardio Diagnostics Holdings, Inc. (-258.81%), greater than Hillstream BioPharma, Inc. (-172.28%), less than SeqLL Inc. (-0.04%),

Build a custom stock screener for Unicycive Therapeutics, Inc. (UNCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Unicycive Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Unicycive Therapeutics, Inc. (UNCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Unicycive Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Unicycive Therapeutics, Inc.'s ROE?

How is the ROE calculated for Unicycive Therapeutics, Inc. (UNCY)?

What is the highest ROE for Unicycive Therapeutics, Inc. (UNCY)?

What is the 3-year average ROE for Unicycive Therapeutics, Inc. (UNCY)?

What is the 5-year average ROE for Unicycive Therapeutics, Inc. (UNCY)?

How does the current ROE for Unicycive Therapeutics, Inc. (UNCY) compare to its historical average?